Incidence and risk factors for COVID-19 associated candidemia (CAC) in ICU patients.

Bircan KayaaslanAyşe Kaya KalemDilek AsilturkBetul KaplanGülen DönertasImran HasanogluFatma EserRuveyda KorkmazerZeynep OktayIsıl Ozkocak TuranDeniz ErdemHesna BektasRahmet Guner

Published in: Mycoses (2022)

Our study filled the knowledge gap in the literature about the impact of COVID-19-associated risk factors for the development of candidemia. The classical risk factors for candidemia had a significant effect on candidemia, and contrary to expectations, corticosteroids had a protective effect against the development of candidemia. The results of these studies showing interesting effects of corticosteroids in critically ill COVID-19 patients should be confirmed by further studies.

Keyphrases

sars cov
coronavirus disease
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
healthcare
intensive care unit
case control
prognostic factors
respiratory syndrome coronavirus